• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

    21.36 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 21.36
    Bid (Size) 21.24 (100)
    Ask (Size) 21.50 (100)
    Prev. Close 21.36
    Today's Range 21.36 - 21.36
    52wk Range 5.635 - 21.43
    Shares Outstanding 73,572,633
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Halper Sadeh LLC is Investigating Whether DAWN, SEM, EWCZ, FONR are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether DAWN, KORE, CECO are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire

    Performance

    YTD
    +141.4%
    +141.4%
    1 Month
    +79.8%
    +79.8%
    3 Month
    +158.3%
    +158.3%
    6 Month
    +197.5%
    +197.5%
    1 Year
    +146.4%
    +146.4%

    More News

    Read More
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Talkspace, Inc. (Nasdaq - TALK), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN), Kennedy-Wilson Holdings, Inc. (NYSE - KW), United Homes Group, Inc. (Nasdaq - UHG)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    The $12.3 Billion Dawn: A Comprehensive Research Feature on Dayforce Inc. (DAWN)
    Via Finterra
    Topics Artificial Intelligence Economy Initial Public Offering
    Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q4 Revenue Beat but Wider Loss, Shares Dip ↗
    Via Chartmill
    News headline image
    Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions ↗
    Via The Motley Fool
    Topics Economy Stocks
    Here are the top movers in Friday's session. ↗
    Via Chartmill
    Which stocks are moving on Friday? ↗
    Via Chartmill
    News headline image
    DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    The market is filled with gapping stocks in Friday's session. ↗
    Via Chartmill
    News headline image
    Why Did DAWN Skyrocket Over 65% Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise ↗
    Via Stocktwits
    Topics Economy
    News headline image
    Day One Bio (DAWN) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    Keep an eye on the top gainers and losers in Monday's session. ↗
    Via Chartmill
    Gapping stocks in Monday's session ↗
    Via Chartmill
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    News headline image
    Day One Completes Acquisition of Mersana Therapeutics
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Day One Biopharmaceuticals, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Day One Biopharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Day One Biopharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Day One Biopharmaceuticals, Inc. - Common Stock trade on?
    Day One Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock is DAWN on the Nasdaq Stock Market
    What is the current price of Day One Biopharmaceuticals, Inc. - Common Stock?
    The current price of Day One Biopharmaceuticals, Inc. - Common Stock is 21.36
    When was Day One Biopharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Day One Biopharmaceuticals, Inc. - Common Stock was at 03/16/26 04:00 PM ET
    What is the market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock?
    The market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock is 1.57B
    How many shares of Day One Biopharmaceuticals, Inc. - Common Stock are outstanding?
    Day One Biopharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.